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Abstract
Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left
ventricular assist device (LVAD) and the native circulation. However, these studies seldom consider the pathological
descending limb of the Frank-Starling response of the overloaded ventricle. This study introduces a dilated heart failure
model featuring a unimodal end systolic pressure-volume relationship (ESPVR) to address this critical shortcoming. The
resulting hemodynamic response to mechanical circulatory support are illustrated through numerical simulations of a
rotodynamic, continuous flow ventricular assist device (cfVAD) coupled to systemic and pulmonary circulations with
baroreflex control. The model further incorporated septal interaction to capture the influence of left ventricular (LV)
unloading on right ventricular function. Four heart failure conditions were simulated (LV and bi-ventricular failure with/
without pulmonary hypertension) in addition to normal baseline. Several metrics of LV function, including cardiac output
and stroke work, exhibited a unimodal response whereby initial unloading improved function, and further unloading
depleted preload reserve thereby reducing ventricular output. The concept of extremal loading was introduced to reflect the
loading condition in which the intrinsic LV stroke work is maximized. Simulation of bi-ventricular failure with pulmonary
hypertension revealed inadequacy of LV support alone. These simulations motivate the implementation of an extremum
tracking feedback controller to potentially optimize ventricular recovery.
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Introduction
Lumped parameter models of mechanical circulatory support
have been employed for the past two decades to simulate
important hemodynamic couplings between a ventricular assist
pump and the native circulation. In the modern era of continuous
flow ventricular assist devices (cfVADs), such models have been
used to identify algorithms for feedback control so as to adequately
unload the native ventricle [1–4], avoid suction [5], and
potentially promote cardiac recovery [6,7]. Surprisingly, only a
few of these simulations [2] have employed models of the diseased
heart that reflect cardiac overload (myocardial overstretch)—one
of the most common characteristics of end stage heart failure.
Instead, the common model of cardiac dysfunction has been to
attenuate ventricular contractility of a healthy heart model,
defined by the classic elastance function of Suga and Sagawa
[8], by reducing the value of maximal elastance (Emax) or shifting
the ESPVR to the right [3,5,9]. This approach presumes a
monotonically increasing, usually linear, ESPVR. But this neglects the
pathological descending limb of the Frank-Starling response of the
overloaded ventricle—beyond the limit of contractile reserve
[10,11] (See Fig. 1.) Consequently, these previous simulations of
mechanical circulatory support unrealistically exhibit supra-
physiologic cardiac contribution with increased preload, as
contrasted with the failing ventricle in which excessive preload
causes a depression in ejection fraction and stroke work [12],
especially in acute non-ischemic cardiomyopathy.
The current study therefore investigates the hemodynamics of
mechanical circulatory support with a more accurate model of the
failing heart, in which the ESPVR is a unimodal function. This
model provides sufficient and necessary conditions for the
existence of a finite, maximum cardiac power output. A lumped
parameter simulation of the systemic and pulmonary circulation
with baroreflex control was implemented numerically, encom-
passing a variety of cardiac pathologies, including combinations of
LV and right ventricular (RV) failure, with and without
pulmonary hypertension. The model further incorporates right-
left ventricular interdependence through the inclusion of an
intraventricular septum element: to capture the influence of
mechanical coupling of the two ventricles through a shared septal
wall [13]. This model enables the investigation of the well-known
leftward shift of the septum due to LV decompression. This effect
is particularly prominent with modern cfVADs which are capable
of unloading the LV to the point of suck-down. In the context of
feedback control for mechanical circulatory support, this simula-
tion study serves as a platform to evaluate extremum-tracking
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control [14,15] as a potential means to optimize ventricular
recovery.
Materials and Methods
Cardiovascular Model
A nonlinear time-varying lumped parameter model of the
circulatory system, described previously by Ursino et al. [16] was
modified to include an intraventricular septum element and a
rotodynamic, continuous flow VAD (cfVAD). (See Fig. 2.)
Elements of the vascular system were simulated using electrical
analogs, wherein flow is represented by current and pressure by
voltage. Passive components, namely resistors, capacitors and
inductors were used to represent hemodynamic resistance,
compliance and inertance, respectively [17]. This cardiovascular
model consisted of the following major components: the numerical
representation of left and right heart; the septum; the systemic and
pulmonary vascular impedances. (See Appendix S1 for details.)
Regulation of arterial pressure was achieved by a baroreflex model
described previously [16].
Instantaneous ventricular pressure PLV (t) was comprised of the
superposition of systolic and diastolic contributions. (See Equation
(1).) The systolic component was in turn the product of a
normalized time-varying activation function e(t) (2) and the
unimodal ESPVR envelope given by (3). For the sake of simplicity,
the ESPVR was idealized by a piecewise bi-linear function. The
corresponding slopes and intercepts were derived from published
clinical data [18]. The end-diastolic pressure-volume relationship
(EDPVR) was defined by the classical exponential function given
in (4). The pressure loss due to viscous dissipation within the
ventricle was reflected in intraventricular resistance RLV (Equation
1) as defined by Shroff et al. [19].
PLV (t)~e(t):PLV ,esz½1{e(t):PLV ,ed{RLV :QAo(t)
0ƒe(t)ƒ1
ð1Þ
e(t)~
sin2 (p:T :f (t)=Tsys) 0ƒf (t)ƒTsys=T
0 Tsys=Tƒf (t)ƒ0
(
ð2Þ
where
PLV ,es~
0
ELVz(VLV{VLV ,u)
ELV{VLVzPLV ,b
8><
>:
VLVƒVLV ,u
VLV ,uvVLVƒ(ELV ,u :VLV ,uzPLV ,b)=(ELVz{ELV{)
VLVw(ELVz:VLV ,uzPLV ,b)=(ELVz{ELV{)
ð3Þ
and,
PLV ,ed~PLV ,0:(e
kLV ,E
:(VLV{VLV ,u){1) ð4Þ
T , above, is the period of the cardiac cycle, f (t) is the time fraction
of cardiac cycle (f (t)~mod(t,T)=T), Tsys is the duration of
cardiac systole; VLV is the instantaneous LV volume, VLV ,u is the
unstressed LV volume; PLV ,b is the pressure axis intercept of the
descending ESPVR. ELVz, ELV{ describe the slopes of piecewise
ascending and descending limbs of simplified nonlinear ESPVR,
respectively [19]; PLV ,0 and kLV ,E are two parameters that define
the end-diastolic pressure-volume relation (EDPVR); and QAo is
the blood flow ejected through the aortic valve. A similar strategy
was utilized to simulate the RV, with corresponding parameters
Figure 1. Illustration of the descending limb of the Starling
curve for dilated heart failure. Adapted from McMichael. [43]
doi:10.1371/journal.pone.0085234.g001
Figure 2. Compartmental lumped-parameter electrical analog
of the circulatory system and continuous flow LVAD (cfLVAD).
doi:10.1371/journal.pone.0085234.g002
ð3Þ
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(provided in the Appendix S1.) The atria were not explicitly
modeled, but incorporated into respective venous reservoirs. The
four heart valves were modeled as ideal diodes: D1 - mitral, D2 -
aortic, D3 - tricuspid, D4 - pulmonary. By application of Kirchoffs
laws, a set of thirteen state equations were derived for the full
model, detailed in the Appendix S1.
To simulate ventricular interdependence, mechanical coupling
between the right and left ventricles through the interventricular
septum was characterized by an interventricular elastance model
developed by Chung et al. [20]. The LV and RV volumes were
decomposed into two parts: the neutral volumes (VLV F andVRV F )
corresponding to zero inter-ventricular (transmural) pressure, and
the septal displaced volume VSPT caused by the shift of the septum
from neutral position towards the RV. Hence:
VLV~VLV FzVSPT ð5Þ
VRV~VRV F{VSPT ð6Þ
where VSPT is governed by the activation function e(t) as follows:
VSPT~e(t)
:VSPT ,esz½1{e(t):VSPT ,ed
~
e(t):
PSPT
Ez
SPT ,es
zVSPT ,d
 
z½1{e(t): 1
lz
SPT
:ln
PSPT
Pz
SPT ,0
z1
 
zVSPT ,0
 
PSPT§0
e(t):
PSPT
E{
SPT ,es
zVSPT ,d
 
z½1{e(t): 1
l{
SPT
:ln {
PSPT
P{
SPT ,0
z1
 
zVSPT ,0
 
PSPTv0
8>><
>>:
ð7Þ
where, PSPT is the pressure difference across the septum:
PSPT~PLV{PRV ð8Þ
The LVAD Model
A model of a rotodynamic, continuous flow LVAD [17] was
connected to the nodes a and b of the cardiovascular model in
Fig. 2, representing ventricular to aortic cannulation. It adds one
state variable to the original mathematical model, namely the
pressure difference across the pump H as a function of VAD flow
and speed:
H~b0QPzb1
LP
Lt
zb2v
2 ð9Þ
where QP is the volumetric flow rate through the pump, v is
the rotational speed, and b0, b1, b2 are constants that define
the resistance, inertance, and speed dependence of the
pump, respectively. For the purpose of the present study,
parameters from a clinically used axial flow pump (HeartMate
II, Thoratec, Pleasanton, CA) were implemented (b0 =0.1707,
b1 =0.02177, b2 =20.0000903) in addition to corresponding
published parameters for the resistance and inertances of the
inflow and outflow cannulae (Ri =Ro =0.0677 mmHg*s/mL;
Li =Lo =0.0127 mmHg*s/mL) [21].
To simulate potential suction events caused by negative pressure
within the LV, an additional nonlinear suction resistor Rk
introduced by Choi was interposed between the inflow cannula
and LV [21]:
Rk~
0 PLVwPth
{3:5PLVz3:5Pth PLVƒPth

ð10Þ
where Pth is the threshold pressure, taken as 1 mmHg.
Simulation Protocol
A series of simulated experiments was conducted under normal
conditions (no LV/RV failure) and four different pathological
conditions [3,22–25]: (1) left ventricular failure (LVF), (2)
biventricular failure (Bi-F), (3) LVF with pulmonary hypertension
(PVR+), and (4) Bi-F with PVR+. The parameter values and
hemodynamic variables derived from computations under these
conditions were derived from the literature and are detailed in
Tables AII-AIV of Appendix S1. Hemodynamic baseline condi-
tions of LVF with/without PVR+ were calibrated with the pre-
operative conditions before LVAD implantation; similarly, base-
line hemodynamics of Bi-F with/without PVR+ with those before
BiVAD implantation [26,27]. Calibration variables included
systolic/diastolic/mean arterial pressure (SBP/DBP/MAP), left
atrial pressure (LAP); right atrial pressure (RAP), systolic/
diastolic/mean pulmonary arterial pressure (PAs/PAd/PAm),
pulmonary capillary wedge pressure (PCWP), transpulmonary
gradient (TPG), pulmonary vascular resistance (PVR), cardiac
output (CO), and left/right ventricular ejection fraction (LVEF/
RVEF).
The effect of the cfLVAD on the hemodynamics was evaluated
in each of the five baseline conditions defined above. LVAD speed
was increased from 6k RPM to 12k RPM in increments of 1k
RPM and ventricular pressure-volume (PV) loops were composed
for each, from which the following indices were evaluated: total
CO (sum of aortic valve flow and LVAD flow), LAP, RAP, LV
stroke volume (SV=VLV ,max{VLV ,min in one cardiac cycle),
stroke work (SW), pre-load adjusted maximal power, fractional
volume change and% change of SV in the simulated scenario with
LVAD compared to the one at the corresponding baseline. The
simulation results were compared with data obtained from
literature and six patient records obtained from the University of
Pittsburgh Medical Center (UPMC) following approval by the
Instititutional Review Board of University of Pittsburgh. Written
consent was given by the patients to enroll in the study and for
their medical information to be stored in the hospital database and
used for research. All of these six patients were initially implanted
with HeartMate II cfLVAD, among which three patients were
identified with cardiac function recovery on LVAD (LVAD-
removal) and the other three relied on the cfLVAD to sustain their
life (LVAD-dependent). The LVAD-removal group tended to be
younger (37+13 vs. 54+16 years); included 2 females (vs. none)
and all patients suffered non-ischemic heart disease (vs. 1 in the
LVAD-dependent group). The duration on LVAD in the two
groups of patients when assessed were similar (93+32 vs. 74+46
days in the LVAD-dependent group).
The results were further analyzed with respect to the optimality
of ventricular support. Specifically, the pump speed at which the
stroke work of the left ventricle was maximized was defined as
Extremal Loading. Increasing pump speed beyond this point caused
reduction of LV contribution due to reduction of preload, and
decreasing speed caused LV overload.
Results
Simulation of Heart Failure Hemodynamics
The parameters of the cardiovascular model parameters were
initialized with nominal values found in the literature, and then
ð7Þ
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optimized through trial-and-error, within the upper and lower
ranges of normal, to approximate the primary hemodynamic
variables of interest. Particular emphasis was placed on cardiac
output (CO). This was performed for the normal and four heart
failure pathological conditions. The corresponding hemodynamic
benchmarks are provided in Table 1. Comparison to clinical
values from various literature sources [26–34] are provided in
Fig. 3. The baseline conditions are provided in Fig. 3a, illustrating
a close approximation by the model to the normal adult profile.
Similarly, the four simulated heart failure conditions were found to
match the clinical hemodynamic data sets recorded pre-opera-
tively in the corresponding benchmark LVAD or BiVAD data.
(See Fig. 3b, c.) Although approximations were made by the
lumped parameter model, most baseline values were within one
standard deviation of the reported data, with the exception of PAs
in LVF, RAP in LVF with/without PVR+, PAd/m in LVF with
PVR+, and DBP in Bi-F without PVR+, which were within two
standard deviations of the data.
Ventricular pressure-volume (PV) loops generated for each of
the simulated conditions are shown in Fig. 4, along with two
intermediate conditions associated with depressed ESPVR and
increased diastolic compliance. The reduction of the slope of the
ascending limb of ESPVR (by 59%) caused a characteristic
depression in systolic pressure as well as a rightward shift of the PV
loops due to translocation of blood to the pulmonary circuit.
Increasing the diastolic compliance, corresponding to remodeling
caused by volume overload, resulted in further increase of LV end-
diastolic volume (EDV). This, in turn, caused the loops to enter the
descending limb of the ESPVR. Similar hemodynamic effects of
RV were observed in the simulated bi-ventricular failure
conditions. (See Fig. 4b.) Elevation of PVR caused a more
dramatic rightward shift in the RV loops than those of the LV in
the conditions of both LVF and Bi-F, respectively. It also caused a
Figure 3. Comparison of baseline simulation data in normal and four pathological conditions with published clinical data and
historical control subjects. (a) Normal patient; (b) pre-operative clinical LVAD data versus simulation baseline of LVF and LVF with PVR+; (c) pre-
operative BiVAD patient data versus simulation baseline of Bi-F and Bi-F with PVR+ conditions. Values are represented as mean +/2 standard
deviation. (Sources: } Rulli et al. 1980 [30], J Nordenfelt et al. 1985 [31], j Normal range for MAP [28]£; Ehrsam et al. 1983 [32], ! Zaret et al. 1984
[33],¥ Thadani et al. 1978 [34], * Dang et al. 2006 [26]; { Fitzpatrick et al. 2008 [27]; } Kormos et al. [29]). All of the abbreviation are defined in Section II,
Part C.
doi:10.1371/journal.pone.0085234.g003
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commensurate increase in pulmonary effective arterial elastance
(Ea), illustrated in Fig. 4b as the slope of end-systolic pressure vs.
stroke volume relation [30], from Ea1 to Ea3, and Ea2 to Ea4,
respectively.
Hemodynamics of LVAD Unloading
Fig. 5a provides the LV stroke work index (assuming 1.9 m2
body surface area [26]) versus end diastolic pressure (SWI-EDP)
for the simulations with the cfLVAD included in the circulation.
Increasing speed through the labeled operating range of the
LVAD (6k–12k RPM) caused a monotonic decrease in EDP for all
four simulated heart failure conditions. However, SWI exhibited a
unimodal characteristic wherein the maximum was found to occur
at approximately 9k RPM in LVF simulation case, 8k RPM in Bi-
F, 7k RPM in LVF with PVR+ and Bi-F with PVR+, respectively.
For the sake of comparison, clinically measured SWI-EDP curves
of five patients with marked LV dysfunction (from Ross and
Braunwald) [12] are juxtaposed (demarcated by the shaded
Table 1. Simulated Hemodynamics for Normal and Four Heart Failure Conditions
Parameters Normal LVF Bi-F LVF, PVR+ Bi-F, PVR+
Cardiac output (L/min) 5.8 3.5 3.2 3.3 2.4
Stroke volume (mL) 68.0 41.1 37.1 39.2 28.6
Left atrial pressure (mean, mmHg) 8.7 26.0 28.0 19.1 18.0
Right atrial pressure (mean, mmHg) 4.4 3.5 17.1 5.1 20.7
Arterial pressure (mmHg)
Systolic 133.0 95.2 98.4 93.0 87.6
Diastolic 93.0 69.4 74.8 68.3 68.0
Mean 106.0 77.3 82.1 75.9 73.8
Pulmonary arterial pressure (mmHg)
Systolic 28.0 37.9 49.8 61.9 49.4
Diastolic 15.0 29.3 31.7 42.3 35.0
Mean 20.1 32.9 37.8 48.9 39.8
LV end-diastolic pressure (mmHg) 10.0 25.6 27.6 18.8 17.8
LV end-diastolic volume (mL) 130.0 245.6 237.1 246.8 256.0
RV end-diastolic pressure (mmHg) 4.0 3.3 16.8 4.8 20.5
RV end-diastolic volume (mL) 121.0 106.4 252.8 125.6 277.5
LV ejection fraction (%) 52 17 16 16 11
RV ejection fraction (%) 56 39 15 31 10
Pulmonary vascular resistance (Wood) 2.0 2.0 3.1 9.0 9.0
Heart rate (bpm) 70 85 85 85 85
See text for abbreviations.
doi:10.1371/journal.pone.0085234.t001
Figure 4. Pressure-volume relationships for normal and four heart failure conditions: (a) left ventricle; (b) right ventricle. The
parameters for unimodal ESPVR in (3) are labeled in (a).
doi:10.1371/journal.pone.0085234.g004
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region). (See Fig. 5b.) The latter data exhibits a similar response to
preload, and illustrates a favorable response to unloading. This
unimodal response is contrary to the prevailing model of a linear
or monotonically increasing ESPVR.
The effects of LVAD support for each of the four pathological
simulations are further illustrated in Fig. 6–9. In the LVF
condition (Fig. 6), as the LVAD speed was increased from 6k to
12k RPM, the PV loops shifted leftward as the total CO increased
from 3.5 to 7.6 L/min. The corresponding decrease in LV preload
was rather dramatic: LAP from 26 mmHg to 4 mmHg and the
end diastolic LV volume from 246 mL to 87 mL; while MAP
increased from 77 to 110 mmHg. Concurrently, the RV preload
(RAP) remained within the normal range, increasing slightly from
3 to 7 mmHg and afterload (PAm) reduced from 29 to 12 mmHg.
The maximum LVSW (83 gm-m/beat) was however achieved at
the intermediate speed of 9k RPM, providing 6.0 L/min total CO.
At this optimal speed, the corresponding LAP was 11 mmHg,
within the normal range and the maximum LV volume was
185 mL.
Fig. 7 provides the hemodynamic effects of LVAD in the Bi-F
condition. In the absence of pulmonary hypertension, the total
cardiac output was minimally affected by RV dysfunction, ranging
from 3.2 to 7.2 L/min over the LVAD speed range of 6k–12k
RPM. The effect of LVAD on the reduction of LAP and the
maximum LV volume was similar to the LVF case: from 28 to
8 mmHg, and from 243 to 81 mL, respectively. Maximal LVSW
(77 gm-m/beat) was achieved at the intermediate speed of 8k
RPM, providing 4.7 L/min total CO. The optimal speed was
however reduced to approximately 8k RPM, at which the
corresponding LAP was 15 mmHg and the maximum LV volume
was 191 mL. The presence of RVF resulted in an elevation of
RAP (17 to 21 mmHg over the speed range) and a commensurate
increase in the maximum RV volume between 252 and 290 mL.
At the optimal speed, RAP and the maximum RV volume were
20 mmHg and 275 mL, respectively.
The introduction of moderate- to severe pulmonary hyperten-
sion to the condition of bi-ventricular failure (Fig. 8) caused a
dramatic reduction in total cardiac output, which did not exceed
3.6 L/min despite maximal LVAD speed. At the lowest speed, 6k
RPM, the total output was approximately 1.9 L/min, equivalent
to the CO without the LVAD and at this speed the LV was
distended into the overloaded region and incapable of generating
sufficient pressure to open the aortic valve. A slight increase in
speed to 7k RPM provided sufficient unloading to increase the LV
contribution, however at this speed the pump output was
inadequate to fully overcome arterial afterload resulting in net
regurgitant flow through the LVAD. A further increase in LVAD
speed to 8k RPM further unloaded the LV, reducing its
contribution, which was compensated by a net positive flow
through the LVAD, resulting in a total CO of 3.3 L/min. Above
8k RPM, the LV was sufficiently unloaded to eliminate aortic flow;
yet the net CO reached a plateau at approximately 3.3–3.6 L/
min, caused by concomitant RV overload (RAPw20 mmHg and
the maximum RV volumew250 mL) which limited venous return
to the left heart.
The hemodynamics were somewhat improved by reversing
RVF; however pulmonary hypertension continued to limit the
overall CO. (See Fig. 9.) Similar to the case of Bi-F with PVR+, the
total CO reached a plateau (4.9 L/min) at 8k RPM LVAD speed,
from which further increase of pump speed caused closure of the
aortic valve. The maximum LVSW (75 gm-m/beat) was attained
at 7k RPM. The PAm remained elevated at approximately
49 mmHg over the full range of LVAD speed. Although the
immediate hemodynamic benefit of LVAD support was limited in
this case, it is important to note the dramatic reduction of LAP
which may, over time, reverse pulmonary congestion and reduce
pulmonary vascular impedance and pulmonary hypertension.
Comparison to Clinical Metrics of Cardiac Recovery
Fig. 10 provides arterial pressure-volume loops from simulation
(end systolic pressure-volume points labeled by black dots)
combined with the locus of arterial end-systolic pressure and area
from six patients enrolled in the UPMC ventricular recovery
study: three of which were deemed LVAD-dependent (Fig. 10a)
Figure 5. (a) Effect of varying LVAD support on LV StrokeWork Index (SWI) for four heart failure simulation cases. The red dots signify
Optimal unloading, denoted with corresponding LVAD speed (kRPM). (b) Unimodal (ascending-descending) preload response resembles clinically
observed severe LV dysfunction reported by Ross and Braunwald [12]. The shaded region indicates envelope of marked heart dysfunction defined by
Ross and Braunwald, and based on the response of LV SWI to volume unloading in five of their patients (JW, MD, CC, IG, RS).
doi:10.1371/journal.pone.0085234.g005
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and three for whom the LVAD was successfully removed
(Fig. 10b). For those patients dependent on LVAD, a decrease
of LVAD speed resulted in enlargement of LV (reflected by
increased end-systolic area: ESA) and compromised AP. Similarly,
the simulation results for the case of LVF demonstrated that
decreasing LVAD speed from extremal loading (9k RPM) lead to
LV dilation and decrease of AP. Fig. 10b illustrates the
corresponding simulation results for the normal (recovered) heart
superimposed with clinical data of the 3 patient who were weaned
from LVAD support. For these patients, a decrease of LVAD
speed caused an increase in AP with only slight increase in ESA
(less than 3 cm2). The simulation replicated this trend: as the
LVAD speed was reduced from 10k to 6k RPM, the AP
continuously increased with a slight increase of VLV ,min. These
results corroborate the underlying assumptions and hypothesis of
the simulation model and thereby facilitate the identification of
cardiac recovery.
Discussion
Continuous-flow LVADs have recently proven their efficacy in
providing long-term circulatory assistance, reversing symptoms of
heart failure and, in certain cases, facilitating cardiac recovery
[35,36]. Nevertheless, strategies for prescribing and regulating the
operating speed of cfLVADs are still ill-defined. This is particularly
true in the context of cardiac recovery, in which ventricular re-
loading may play an important therapeutic role [37].
This study was designed to investigate the relationship of level of
mechanical circulatory support upon hemodynamics and ventric-
ular energetics, in the context of dilated heart failure. The main
findings provided by a lumped parameter simulation are: (1) a
rightward shift of the pressure-volume (PV) loop, (2) a concomitent
decrease in LVESP, (3) increase of LVEDP and LVEDV, and (4)
in the most severe cases of cardiac overloaded, the ventricle
exhibits a paradoxical response to preload wherein both LVESP
and stroke volume decrease with increasing preload.
A novel feature of this model was the incorporation of a
pathological ESPVR that represents the over-distended ventricle
more accurately than a conventional, monotonically increasing
function. The ventricular ESPVR has most commonly been
regarded as linear, but in some cases has been represented by a
quadratic function, flattening with high preload [38,39]. In one
such study, Burkhoff et al., working with isolated dog hearts, found
that the curvilinearity of the ESPVR is dependent upon
contractility [40]. By extrapolating the ESPVR with a descending
limb, rather than an ever increasing function, the dilated ventricle
exhibited a unimodal Starling curve: having a maximal point of
preload reserve, beyond which incremental distention caused a
Figure 6. Simulated hemodynamics over a range of LVAD support (from 6k to 12k RPM) for the case of LV failure. With increased
speed, the LV PV loops shift leftward, while the locus of maximal LV pressure exhibited unimodal response with a peak at 9k RPM, also reflected in
LVSW. Total cardiac output however increased monotonically with LVAD speed, although the LV contribution decreased precipitously for speeds
above 9k RPM. (LVP: left ventricular pressure; RVP: right ventricular pressure; LVSW: left ventricular stroke work; MAP: mean arterial pressure; PAm:
mean pulmonary arterial pressure; LAP: mean left atrial pressure; RAP: mean right atrial pressure.)
doi:10.1371/journal.pone.0085234.g006
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decline in output. We explicitly elected to use a bilinear, rather
than a parabolic, approximation so as to to parameterize the
overloaded ventricle with three physically-meaningful values: the
slope of the traditional ESPVR, an additional pathological
descending ESPVR, and the transition point there between.
Because the PV loops straddle the transition cusp its shape (sharp
versus rounded) had no effect on the resulting PV loops.
Due to limiting effect of the EDPVR, the use of a monotonically
increasing ESPVR will not necessarily cause unbounded cardiac
output. However, a monotonic model of the overloaded,
decompensated ventricle is clearly inadequate for characterizing
the therapeutic effect of decompression.
It should be acknowledged that there are a variety of
mechanisms that may be responsible for the descending portion
of ESPVR. In the acutely overloaded heart, there is the possibility
for energy starvation, leading to muscle exhaustion. [41] In the
words of E.H. Starling, when dilatation exceeds the optimum
length of the muscle fiber and the muscle has to contract at such a
mechanical disadvantage the heart fails altogether. [10]. Modern
studies of mechanical circulatory support also allow for the
possibility that sarcomeres may become stretched beyond their
Starling reserve [36,48].
Mitral regurgitation is another likely condition presented in
chronic dilatation due to the distortion of the mitral annulus.
Reversal, or alleviation of volume overload, for example by
diuresis, has been shown to increase stroke volume with decreasing
preload. [42,43]. This is also consistent with the observations of
Gorcsan et al. who observed an increase in cardiac contraction
with LVAD unloading. [44]. While our simulation model, in fact,
includes parameters for mitral and tricuspid insufficiency, we
consciously elected to omit this condition from the present study so
as to independently reveal the importance of the descending limb.
Furthermore, the addition of these parameters as independent
variables would render the experimental matrix unwieldy.
Within this context, the current simulation studies introduced a
concept of extremal loading. This was identified as the degree of
VAD support for which LV stroke work is maximized. Above this
level of support, the incremental improvement in net cardiac
output is diminished, and eventually reaches an asymptote,
constrained by venous return and/or RV output. Although
impossible to prove here, it is reasonable to hypothesize that this
represents a speed set-point for feedback control that is advanta-
geous to myocardial rehabilitation. While it may be controversial
whether physiologic ventricular loading or cardiac exercise
promotes reverse remodeling, there exists sufficient clinical
evidence that chronic unloading results in myocardial disuse atrophy
[45–48]. A future simulation study should be conducted that
focuses specifically on the variety of independent variables that
may effect remodeling.
The obvious implication is that under certain circumstances it
would be undesirable to operate the LVAD at full support. This
may appear contrary to clinical intuition: to place an artificial
Figure 7. Simulated hemodynamics over a range of LVAD support (from 6k to 12k RPM) for the case of bi-ventricular failure. The
peak LVSW occurred at a lower speed than the case of LVF alone (8k RPM versus 9k RPM.)
doi:10.1371/journal.pone.0085234.g007
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constraint on cardiac output. On the other hand, these simulations
demonstrated that the incremental gain in pump output above the
optimal speed was counteracted by a diminution of cardiac
contribution, resulting in a zero-sum gain. Furthermore, there is
growing evidence of the benefit of allowing the aortic valve to open
periodically [36,49]. This can only be achieved if the level of
LVAD support is restricted, so as to allow sufficient preload to the
native heart.
A further clinical consideration that would favor less-than-
maximal LVAD output is the potential for exacerbating RV
dysfunction [13]. These simulations illustrated the delicate balance
between RV preload, afterload, and septal decompression,
particularly in the case of pulmonary hypertension. For example,
in the simulated case of biventricular failure, the reduction in
pulmonary pressure permitted the RV to respond favorably to
increased demand. In the extreme case of biventricular disease
combined with elevated PVR, LVAD support alone was
insufficient for restoring adequate hemodynamics.
Inasmuch as the ESPVR function is not static, but dependent
on time-varying factors such as the progression/reversal of disease,
inotropic state, duration of volume overload, etc., the model
presented here is intended to be illustrative rather than definitive.
The chosen point of extremal loading was somewhat arbitrary, as
it would depend on the body mass index (BMI) as well as etiology
and extent of dilatation. Hence, any mechanical circulatory
support strategy based on this function should be personalized to a
given patient. And since the function is time-varying, there is a
need for continuous feedback control.
This is however confounded by the unavailability of observable
state variables (pressure, flow, volume, etc.) in the actual clinical
setting. Therefore they must be inferred from readily measurable
sources, such as the electrical signals from the VAD itself [5]. In
addition, minimally invasive measurements may be obtained
periodically to assess ventricular function, such as the echocar-
diographic protocol described by Gorcsan et al. [44]. By varying
the degree of VAD support it becomes possible to assess preload
response and thereby calibrate a simulation model, personalized
for a patient.
Apart from feedback control, the simulation model affords the
opportunity to perform in-silico interventions, such as vasoactive
drugs, diuretics, correction of mitral regurgitation, insertion of a
right ventricular assist device, etc. It is also hoped that this
simulation model may be employed to provide greater confidence
for manual adjustment of pump speed, which is commonly
avoided for fear of ventricular suck down, regurgitant flow, or
ventricular overload.
While the present model defines the point of overload in terms
of end systolic volume, physiologically it would be more correct to
define it in terms of a critical sarcomere stretch, hence end-
diastolic volume. A model based on this premise would not be
readily compatible with the mathematical formulation here, but
could possibly be implemented in terms of a unimodal SWI-EDV
model. However, resulting hemodynamic response to LVAD
Figure 8. Simulated hemodynamics over a range of LVAD support (from 6k to 12k RPM) for the case of bi-ventricular failure with
pulmonary hypertension.
doi:10.1371/journal.pone.0085234.g008
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support would be equivalent; inasmuch as the latter relationship is
defined implicitly, rather than explicitly.
An additional limitation of the present model is omission of
pathological vascular regulation that is common to end-stage heart
failure. In lieu of an established rennin-angiotensin- aldosterone
model, these regulatory effects could be introduced manually into
the current baroreflex model in a future extension of this work. An
additional aspect of cardiac failure that would be interesting to
Figure 9. Simulated hemodynamics over a range of LVAD support (from 6k to 12k RPM) for the case of LV failure with pulmonary
hypertension. The total CO reached a plateau at LVAD speed of 8k RPM.
doi:10.1371/journal.pone.0085234.g009
Figure 10. Comparison of clinical recording of end systolic arterial pressure (AP) vs. LV area (LVA) recorded by echocardiography
and finger plethysmography (solid lines) with corresponding simulation (dashed lines.) (a) Patients who were deemed VAD dependent
exhibit decrease of AP with decreased VAD support (increased preload); (b) whereas patients who were successfully weaned from LVAD support
exhibited a physiological preload response: increasing AP with increased preload. The simulations (in which LVV was substituted for LVA) exhibited
similar behavior.
doi:10.1371/journal.pone.0085234.g010
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incorporate into a future study would be intra-ventricular
dyssynchrony.
This study made a best effort to assure the accuracy of the
simulation model presented here by reference to various data
sources from the literature. However, definitive validation will
require data from actual patients receiving cfLVAD support that
exhibit a spectrum of heart failure. This is the goal of an ongoing
clinical study by our group. Until such corroborating data are
available, the present study serves as a prototypical template upon
which a clinical study may be designed.
The future direction of this research will be to also develop
extremum-tracking controllers [14,15] that account for the
observed unimodal response of the LV to unloading, and
specifically to seek the optimal degree of unloading to guide
cfLVAD therapy.
Supporting Information
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vascular impedances; Kirchoffs set of thirteen state equations
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pathological conditions.
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